Brief: Clearside Biomedical Positive Oasis And Extension Study Data Presented At The Retina Society 56Th Annual Scientific Meeting

Clearside Biomedical,

16/10/2023 12:12

Oct 16 (Reuters) - Clearside Biomedical Inc  CLSD.O :
    * CLEARSIDE BIOMEDICAL POSITIVE OASIS AND EXTENSION STUDY
DATA
PRESENTED AT THE RETINA SOCIETY 56TH ANNUAL SCIENTIFIC MEETING
    * CLEARSIDE BIOMEDICAL INC - - ODYSSEY PHASE 2B CLINICAL
TRIAL
ENROLLMENT IS ON TRACK WITH DATA EXPECTED IN Q3 2024
    * CLEARSIDE BIOMEDICAL INC - ODYSSEY PHASE 2B CLINICAL TRIAL
ENROLLMENT IS ON TRACK WITH DATA EXPECTED IN Q3 2024
    * CLEARSIDE BIOMEDICAL INC - EXCELLENT SAFETY PROFILE,
STABLE
VISION, AND REDUCED FREQUENCY OF INJECTIONS OBSERVED FOR UP TO 6
MONTHS

Source text for Eikon:  ID:nGNXb9q9vW 
Further company coverage:  CLSD.O 

 ((Reuters.Briefs@thomsonreuters.com))